Myeloproliferative neoplasm medical therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) m (Gerald Chi moved page Myeloproliferative disease medical therapy to Myeloproliferative neoplasm medical therapy) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myeloproliferative disease}} | {{Myeloproliferative disease}} | ||
{{CMG}} {{AE}} {{MJK}} | |||
==Overview== | |||
The mainstay of therapy for myeloproliferative neoplasm is [[chemotherapy]], [[aspirin]], and palliative care.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/leukemia/hp/cml-treatment-pdq#section/_19</ref><ref>{{Cite journal | |||
| author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | |||
| title = Digitoxin metabolism by rat liver microsomes | |||
| journal = [[Biochemical pharmacology]] | |||
| volume = 24 | |||
| issue = 17 | |||
| pages = 1639–1641 | |||
| year = 1975 | |||
| month = September | |||
| pmid = 10 | |||
}}</ref> | |||
==Medical Therapy== | |||
The mainstay of therapy for myeloproliferative neoplasm is [[chemotherapy]], [[aspirin]], and palliative care.<ref>{{Cite journal | |||
| author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | |||
| title = Digitoxin metabolism by rat liver microsomes | |||
| journal = [[Biochemical pharmacology]] | |||
| volume = 24 | |||
| issue = 17 | |||
| pages = 1639–1641 | |||
| year = 1975 | |||
| month = September | |||
| pmid = 10 | |||
}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology | [[Category:Hematology]] | ||
[[Category: Disease]] | [[Category: Disease]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:35, 26 October 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm medical therapy On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm medical therapy |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The mainstay of therapy for myeloproliferative neoplasm is chemotherapy, aspirin, and palliative care.[1][2]
Medical Therapy
The mainstay of therapy for myeloproliferative neoplasm is chemotherapy, aspirin, and palliative care.[3]
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/leukemia/hp/cml-treatment-pdq#section/_19
- ↑ A. Schmoldt, H. F. Benthe & G. Haberland (1975). "Digitoxin metabolism by rat liver microsomes". Biochemical pharmacology. 24 (17): 1639–1641. PMID 10. Unknown parameter
|month=ignored (help) - ↑ A. Schmoldt, H. F. Benthe & G. Haberland (1975). "Digitoxin metabolism by rat liver microsomes". Biochemical pharmacology. 24 (17): 1639–1641. PMID 10. Unknown parameter
|month=ignored (help)